Glenmede Trust’s Innovid Corp. CTV Stock Holding History

Glenmede Trust’s Portfolio CTV Stock Details CTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-59,160	Closed	-$357K	–	1387
2022 Q1	$357K	Sell	59,160 -108,000	-65%	-$592K	﹤0.01%	995
2021 Q4	$1.11M	Buy	+167,160	New	+$1.52M	0.01%	708

Other funds holding CTV

SIIG

SC Israel IV Genpar Herzelia, Israel $17.5M AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IAC

ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICP

ION Crossover Partners Herzliya Pituach, Israel $36.9M AUM

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Glenmede Trust's CTV Position: Q2 2022 in Review

Glenmede Trust sold out of Innovid Corp. (CTV) in Q2 2022, closing a stake of 59,160 shares — an estimated $357K sold.

Glenmede Trust first reported a position in CTV in Q4 2021 and held it in 2 quarters. The position peaked at $1.11M in Q4 2021. 56 funds tracked by Wall St. Rank hold CTV as of Q2 2022.

Glenmede Trust reported no remaining Innovid Corp. position as of Q2 2022 after selling out during the quarter.
Glenmede Trust sold 59,160 Innovid Corp. shares in Q2 2022, an estimated $357K.
Glenmede Trust first reported a position in Innovid Corp. in Q4 2021 and held it in 2 quarters.
Glenmede Trust's Innovid Corp. position peaked at $1.11M in Q4 2021.
56 funds tracked by Wall St. Rank held Innovid Corp. as of Q2 2022.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.